{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:59:31Z","timestamp":1792202371293,"version":"4.4.0"},"reference-count":71,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,2]]},"DOI":"10.4269\/ajtmh.20-0852","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T07:01:02Z","timestamp":1603177262000},"page":"2224-2232","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic Efficacy of Artemether\u2013Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia"],"prefix":"10.4269","volume":"103","author":[{"given":"Matthew M.","family":"Ippolito","sequence":"first","affiliation":[{"name":"The Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"},{"name":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"},{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Pringle","sequence":"additional","affiliation":[{"name":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwiche","family":"Siame","sequence":"additional","affiliation":[{"name":"Ministry of Health, Government of the Republic of Zambia, Lusaka, Zambia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Katowa","sequence":"additional","affiliation":[{"name":"Macha Research Trust, Macha, Zambia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Aydemir","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Oluoch","sequence":"additional","affiliation":[{"name":"Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya;"},{"name":"Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liusheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University of California San Francisco School of Pharmacy, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca T.","family":"Aweeka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, University of California San Francisco School of Pharmacy, San Francisco, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Juliano","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Meshnick","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"The Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"},{"name":"Division of Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"The Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"},{"name":"W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Thuma","sequence":"additional","affiliation":[{"name":"Macha Research Trust, Macha, Zambia;"},{"name":"The Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","volume-title":"Methods of Surveillance of Antimalarial Drug Efficacy","year":"2009"},{"key":"b2","volume-title":"World Malaria Report","year":"2019"},{"key":"b3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4269\/ajtmh.2011.10-0617a","article-title":"Scaling up malaria control in Zambia: progress and impact 2005\u20132008","volume":"84","author":"Spence-Lewis","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"b4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4269\/ajtmh.2008.79.45","article-title":"National malaria control and scaling up for impact: the Zambia experience through 2006","volume":"79","author":"Steketee","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"b5","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/1475-2875-8-S1-S8","article-title":"Impact of the large-scale deployment of artemether\/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia","volume":"8","author":"Barnes","year":"2009","journal-title":"Malar J"},{"key":"b6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4269\/ajtmh.19-0659","article-title":"Impact of four rounds of mass drug administration with dihydroartemisinin-piperaquine implemented in Southern Province, Zambia","volume":"103","author":"Eisele","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"b7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/1475-2875-13-430","article-title":"Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia","volume":"13","author":"Hamainza","year":"2014","journal-title":"Malar J"},{"key":"b8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1475-2875-5-73","article-title":"Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults","volume":"5","author":"Mulenga","year":"2006","journal-title":"Malar J"},{"key":"b9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12936-019-2818-7","article-title":"Efficacy and safety of artemether-lumefantrine as treatment for Plasmodium falciparum uncomplicated malaria in adult patients on efavirenz-based antiretroviral therapy in Zambia: an open label non-randomized interventional trial","volume":"18","author":"Banda","year":"2019","journal-title":"Malar J"},{"key":"b10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"b11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"b12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malar J"},{"key":"b13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1186\/1475-2875-12-411","article-title":"Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives","volume":"12","author":"Flegg","year":"2013","journal-title":"Malar J"},{"key":"b14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12936-015-0874-1","article-title":"Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis","volume":"14","year":"2015","journal-title":"Malar J"},{"key":"b15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12936-018-2631-8","article-title":"Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model","volume":"18","author":"Sharifi-Malvajerdi","year":"2019","journal-title":"Malar J"},{"key":"b16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR Network","volume":"93","author":"Cui","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"b17","doi-asserted-by":"crossref","first-page":"e02382-16","DOI":"10.1128\/AAC.02382-16","article-title":"pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether-lumefantrine in the United Kingdom","volume":"61","author":"Sutherland","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"b18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1612765","article-title":"Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa","volume":"376","author":"Lu","year":"2017","journal-title":"N Engl J Med"},{"key":"b19","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/s41598-020-60549-7","article-title":"Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in southeast of Tanzania","volume":"10","author":"Bwire","year":"2020","journal-title":"Sci Rep"},{"key":"b20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3201\/eid2404.170141","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014\u20132016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"b21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1475-2875-5-127","article-title":"Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria","volume":"5","author":"Stepniewska","year":"2006","journal-title":"Malar J"},{"key":"b22","doi-asserted-by":"crossref","first-page":"17790","DOI":"10.1038\/s41598-019-54203-0","article-title":"Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs","volume":"9","author":"Gruenberg","year":"2019","journal-title":"Sci Rep"},{"key":"b23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"b24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/infdis\/jiw338","article-title":"Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria","volume":"214","author":"Tchaparian","year":"2016","journal-title":"J Infect Dis"},{"key":"b25","doi-asserted-by":"crossref","first-page":"e0156717","DOI":"10.1371\/journal.pone.0156717","article-title":"Individual and household level risk factors associated with malaria in Nchelenge district, a region with perennial transmission: a serial cross-sectional study from 2012 to 2015","volume":"11","author":"Pinchoff","year":"2016","journal-title":"PLoS One"},{"key":"b26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.4269\/ajtmh.15-0735","article-title":"Habitat partitioning of malaria vectors in Nchelenge district, Zambia","volume":"94","author":"Das","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"b27","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4269\/ajtmh.17-1017","article-title":"Risk factors for mortality in children hospitalized with severe malaria in northern Zambia: a retrospective case-control study","volume":"98","author":"Ippolito","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"b28","volume-title":"WHO Child Growth Standards: Length\/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development","year":"2006"},{"key":"b29","volume-title":"Susceptibility of Plasmodium falciparum to Antimalarial Drugs: Report on Global Monitoring 1996\u20132004","year":"2005"},{"key":"b30","volume-title":"Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations","year":"2007"},{"key":"b31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpba.2018.04.002","article-title":"Semi-quantitative measurement of the antimalarial lumefantrine from untreated dried blood spots using LC-MS\/MS","volume":"155","author":"Ippolito","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"b32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4155\/bio.11.303","article-title":"Determination of lumefantrine in small-volume human plasma by LC-MS\/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation","volume":"4","author":"Huang","year":"2012","journal-title":"Bioanalysis"},{"key":"b33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1023\/A:1016088609005","article-title":"Evaluation of pharmacokinetic studies: is it useful to take into account concentrations below the limit of quantification?","volume":"13","author":"Humbert","year":"1996","journal-title":"Pharm Res"},{"key":"b34","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1007\/s11095-012-0805-6","article-title":"Use of pharmacokinetic data below lower limit of quantitation values","volume":"29","author":"Jusko","year":"2012","journal-title":"Pharm Res"},{"key":"b35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0035-9203(99)90120-7","article-title":"Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand","volume":"93","author":"Snounou","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b36","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12936-017-2137-9","article-title":"A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity","volume":"16","author":"Miller","year":"2017","journal-title":"Malar J"},{"key":"b37","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/nar\/gkx1201","article-title":"SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing","volume":"46","author":"Hathaway","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"b38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/infdis\/jiy223","article-title":"Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes","volume":"218","author":"Aydemir","year":"2018","journal-title":"J Infect Dis"},{"key":"b39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/503423","article-title":"Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria","volume":"42","author":"Price","year":"2006","journal-title":"Clin Infect Dis"},{"key":"b40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/jis747","article-title":"Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms","volume":"207","author":"Malmberg","year":"2013","journal-title":"J Infect Dis"},{"key":"b41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"b42","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"b43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat Genet"},{"key":"b44","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/infdis\/jiy637","article-title":"Comparative efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Ugandan children","volume":"219","author":"Yeka","year":"2019","journal-title":"J Infect Dis"},{"key":"b45","first-page":"49","article-title":"Efficacy and tolerability of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites across Cote d\u2019Ivore","volume":"64","author":"Konate","year":"2018","journal-title":"Ann Parasitol"},{"key":"b46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12936-016-1091-2","article-title":"Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin","volume":"15","author":"Ogouyemi-Hounto","year":"2016","journal-title":"Malar J"},{"key":"b47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","article-title":"Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015","volume":"16","author":"Plucinski","year":"2017","journal-title":"Malar J"},{"key":"b48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12936-018-2200-1","article-title":"Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger","volume":"17","author":"Grandesso","year":"2018","journal-title":"Malar J"},{"key":"b49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/imr.12697","article-title":"Within-host modeling of blood-stage malaria","volume":"285","author":"Khoury","year":"2018","journal-title":"Immunol Rev"},{"key":"b50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1475-2875-10-278","article-title":"The parasite clearance curve","volume":"10","author":"White","year":"2011","journal-title":"Malar J"},{"key":"b51","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat Commun"},{"key":"b52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/jiw234","article-title":"Defining the effectiveness of antimalarial chemotherapy: investigation of the lag in parasite clearance following drug administration","volume":"214","author":"Khoury","year":"2016","journal-title":"J Infect Dis"},{"key":"b53","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/infdis\/jiy673","article-title":"Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria","volume":"219","author":"Intharabut","year":"2019","journal-title":"J Infect Dis"},{"key":"b54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.pt.2020.02.005","article-title":"Malaria parasite clearance: what are we really measuring?","volume":"36","author":"Khoury","year":"2020","journal-title":"Trends Parasitol"},{"key":"b55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/cid\/cix336","article-title":"The relative effects of artemether-lumefantrine and non-artemisinin antimalarials on gametocyte carriage and transmission of Plasmodium falciparum: a systematic review and meta-analysis","volume":"65","author":"Ippolito","year":"2017","journal-title":"Clin Infect Dis"},{"key":"b56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/CMR.00051-10","article-title":"Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination","volume":"24","author":"Bousema","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"b57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-016-0621-7","article-title":"Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data","volume":"14","year":"2016","journal-title":"BMC Med"},{"key":"b58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","article-title":"Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients","volume":"46","author":"Ezzet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"b59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpba.2007.07.015","article-title":"Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper","volume":"45","author":"Blessborn","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"b60","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria","volume":"44","author":"Ezzet","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"b61","doi-asserted-by":"crossref","first-page":"e02476-17","DOI":"10.1128\/AAC.02476-17","article-title":"Characterizing blood-stage antimalarial drug MIC values in vivo using reinfection patterns","volume":"62","author":"Watson","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"b62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1475-2875-12-254","article-title":"A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya","volume":"12","author":"Agarwal","year":"2013","journal-title":"Malar J"},{"key":"b63","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s13071-016-1786-9","article-title":"Spatio-temporal heterogeneity of malaria vectors in northern Zambia: implications for vector control","volume":"9","author":"Stevenson","year":"2016","journal-title":"Parasit Vectors"},{"key":"b64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1473-3099(17)30006-3","article-title":"The challenge of imported malaria to eliminating countries","volume":"17","author":"Liu","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"b65","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.4269\/ajtmh.15-0283","article-title":"Predictive malaria risk and uncertainty mapping in Nchelenge district, Zambia: evidence of widespread, persistent risk and implications for targeted interventions","volume":"93","author":"Pinchoff","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"b66","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12936-016-1637-3","article-title":"The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia","volume":"15","author":"Mwanza","year":"2016","journal-title":"Malar J"},{"key":"b67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.actatropica.2016.09.008","article-title":"Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda","volume":"164","author":"Kateera","year":"2016","journal-title":"Acta Trop"},{"key":"b68","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/infdis\/jiu216","article-title":"Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi","volume":"210","author":"Frosch","year":"2014","journal-title":"J Infect Dis"},{"key":"b69","doi-asserted-by":"crossref","first-page":"jiaa368","DOI":"10.1093\/infdis\/jiaa368","article-title":"Steep rebound of chloroquine sensitive Plasmodium falciparum in Zimbabwe","author":"Mharakurwa","year":"2020","journal-title":"J Infect Dis"},{"key":"b70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","article-title":"The public health impact of chloroquine resistance in Africa","volume":"64","author":"Trape","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"b71","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:43:14Z","timestamp":1611769394000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12,2]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0852","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,2]]}}}